UiPath Stock Is Down 35% This Year – Is This a Buying Opportunity or a Falling Knife?

Situated on the 60th floor of one of New York’s more recent skyscrapers, the offices at One Vanderbilt Avenue in midtown Manhattan offer views that, on a clear day, span the Hudson and beyond. It’s the address a business chooses when it wants the world to know it has arrived; it’s the kind of address that conveys ambition.

That kind of confidence was undoubtedly projected by UiPath, the automation software company with Romanian roots that went public on the New York Stock Exchange in 2021 at valuations that momentarily approached the stratosphere. The stock that is currently trading under the PATH ticker tells a much more subdued tale.

On March 27, 2026, shares ended the day at $10.69, down over 3%. They were below the 20-day moving average of $11.57, below the 50-day at $12.21, and significantly below the 200-day at $13.36. The stock has dropped by almost 35% so far this year. PATH has dropped by about 88% from its all-time high of $90, which was briefly attained in May 2021 during the euphoric weeks following its IPO when every enterprise software company with an AI-adjacent pitch was receiving a premium that would seem, in hindsight, a little insane. It’s not a correction. It’s a reckoning.

The gap between the business and the price action is what makes the current situation genuinely fascinating and frustrating for stockholders. In the traditional sense, UiPath is not a failing business. Most software companies would consider its gross margins of 83.21 percent to be exceptional. The most recent quarter saw a 13.56 percent year-over-year increase in revenue and a nearly 18 percent beat in earnings per share. The trailing twelve months’ revenue was $1.611 billion.

The company’s balance sheet shows $1.69 billion in cash and marketable securities, which is sufficient to finance operations for years without requiring access to outside markets. A $500 million share buyback, which at current prices amounts to almost 9% of the total market capitalization, was approved by management. These are not the figures of a troubled business.

However, the market is largely uninterested in UiPath, with sporadic instances of active marketing. The announcement of the buyback had no effect. The announcement that would have caused the stock to rise by 10% in 2021—the introduction of new agentic AI solutions aimed at the manufacturing, retail, and finance sectors—landed with a muted thud.

More analyst notes were generated than price movement even after Raghu Malpani was promoted to Chief Product and Technology Officer, indicating that leadership is investing in its AI direction. Regardless of what the story actually says, there’s a sense as this develops that the market has just stopped believing it for the time being.

A layer of dark humor is added by the Jim Cramer footnote. The stock responded to the CNBC host’s recent statement that UiPath wasn’t for him by declining even more the following day. It almost doesn’t matter if that’s a coincidence or a cause; what matters is that it expresses the sentiment issue UiPath is facing. Good news is not helpful.

Commentary that is neutral is painful. With support being tested at $9.38 and resistance at the Ichimoku Kijun line around $11.12, the technical structure is presenting a bearish narrative that the fundamentals haven’t yet been able to break. The market is effectively penalizing UiPath for not reacting to positive news, according to Traders Union analysts. Once this dynamic is established, it can become self-reinforcing and is notoriously difficult to break without a catalytic event.

When UiPath releases its upcoming quarterly earnings in May, that event might occur. For a software company with 83 percent gross margins growing at double digits, the forward price-to-earnings ratio is about 13 times, which is genuinely inexpensive, assuming growth continues.

If that view is accurate, the one-year analyst price target consensus is approximately $13.81, which suggests an increase of about 29% from current levels. Technical models’ long-term forecasts point to a three-month increase of 32%, but short-term signals are still negative and the $10.23 support level is said to be actively at risk.

In 2005, UiPath began as a small AI research company in Bucharest. This is the kind of founding story that is presented in conference rooms and on keynote slides as proof that successful businesses can originate from anywhere. It was developed by Daniel Dines into a true enterprise platform, which is used by governments, banks, and hospitals to automate repetitive, rule-based tasks that consume a significant amount of human time. That fundamental business is still the same.

In a market that is obviously heading in that direction, the agentic AI pivot—which goes beyond robotic process automation into systems where AI agents can autonomously handle complex multi-step workflows—is a viable strategic move. Whether UiPath implements that change quickly and persuasively enough to win back institutional investors who have mostly shifted their focus is still up in the air.

The price of the stock has decreased. It reached its lowest point in its public history in April 2025, at $9.38. By December of that year, it had recovered to almost $20 before giving up all of the gains. That level of volatility—moving from close to its floor to close to its high and back in just eight months—indicates how erratic the market’s perception of this business is. Not damaged. Not resolved. In the middle, waiting for an excuse to take a firm step in either direction.